Stayble Therapeutics (Sweden) Today
| STABL Stock | SEK 0.47 0.04 7.84% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Stayble Therapeutics is selling for under 0.47 as of the 1st of February 2025; that is 7.84 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.44. Stayble Therapeutics has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 5th of August 2024 and ending today, the 1st of February 2025. Click here to learn more.
Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration. Stayble Therapeutics AB is based in Gothenburg, Sweden. Stayble Therapeutics is traded on Stockholm Stock Exchange in Sweden. The company has 13.85 M outstanding shares. More on Stayble Therapeutics AB
Moving together with Stayble Stock
Moving against Stayble Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Stayble Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Stayble Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Stayble Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Stayble Therapeutics AB (STABL) is traded on Stockholm Exchange in Sweden and employs 3 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Stayble Therapeutics's market, we take the total number of its shares issued and multiply it by Stayble Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Stayble Therapeutics operates under Healthcare sector and is part of Biotechnology industry. The entity has 13.85 M outstanding shares.
Stayble Therapeutics AB has accumulated about 42.71 M in cash with (9.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Stayble Therapeutics Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Stayble Therapeutics is kr49.02 Million. Stayble Therapeutics maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Stayble Ownership Details
Stayble Therapeutics Risk Profiles
Although Stayble Therapeutics' alpha and beta are two of the key measurements used to evaluate Stayble Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.0 | |||
| Standard Deviation | 6.42 | |||
| Variance | 41.27 | |||
| Risk Adjusted Performance | (0.02) |
Stayble Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Stayble Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Stayble Therapeutics Corporate Management
Elected by the shareholders, the Stayble Therapeutics' board of directors comprises two types of representatives: Stayble Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stayble. The board's role is to monitor Stayble Therapeutics' management team and ensure that shareholders' interests are well served. Stayble Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stayble Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anders Lehmann | Chief Officer | Profile | |
| Mattias MSc | CoFounder Officer | Profile | |
| Andreas MSc | CoFounder CEO | Profile | |
| Thomas MSc | Chief Officer | Profile |
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.